{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:31:23Z","timestamp":1790127083190,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15227-x","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:34:43Z","timestamp":1754926483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploration of autophagy-associated genes and potential molecular mechanisms in type 1 diabetes and osteoporosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Houyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaCong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIzhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"15227_CR1","doi-asserted-by":"publisher","unstructured":"Hamann, C., Kirschner, S., G\u00fcnther, K. P. & Hofbauer, L. C. Bone, sweet bone\u2013osteoporotic fractures in diabetes mellitus. Nat. Rev. Endocrinol. 8 (5), 297\u2013305. https:\/\/doi.org\/10.1038\/nrendo.2011.233 (Jan. 2012).","DOI":"10.1038\/nrendo.2011.233"},{"key":"15227_CR2","doi-asserted-by":"publisher","unstructured":"Cheng, T. et al. Genetically determined type 1 diabetes mellitus and risk of osteoporosis. Exp. Gerontol. 191, 112434. https:\/\/doi.org\/10.1016\/j.exger.2024.112434 (Jun. 2024).","DOI":"10.1016\/j.exger.2024.112434"},{"key":"15227_CR3","doi-asserted-by":"publisher","unstructured":"Dhaon, P. & Shah, V. N. Type 1 diabetes and osteoporosis: a review of literature, Indian J. Endocrinol. Metab., vol. 18, no. 2, pp. 159\u2013165, Mar. (2014). https:\/\/doi.org\/10.4103\/2230-8210.129105","DOI":"10.4103\/2230-8210.129105"},{"key":"15227_CR4","doi-asserted-by":"publisher","unstructured":"Johnston, C. B. & Dagar, M. Osteoporosis in older adults. Med. Clin. North. Am. 104 (5), 873\u2013884. https:\/\/doi.org\/10.1016\/j.mcna.2020.06.004 (Sep. 2020).","DOI":"10.1016\/j.mcna.2020.06.004"},{"key":"15227_CR5","doi-asserted-by":"publisher","unstructured":"Eizirik, D. L., Pasquali, L. & Cnop, M. Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure, Nat. Rev. Endocrinol., vol. 16, no. 7, pp. 349\u2013362, Jul. (2020). https:\/\/doi.org\/10.1038\/s41574-020-0355-7","DOI":"10.1038\/s41574-020-0355-7"},{"key":"15227_CR6","doi-asserted-by":"publisher","unstructured":"Syed, F. Z. Type 1 diabetes mellitus. Ann. Intern. Med. 175 (3), ITC33\u2013ITC48. https:\/\/doi.org\/10.7326\/AITC202203150 (Mar. 2022).","DOI":"10.7326\/AITC202203150"},{"key":"15227_CR7","doi-asserted-by":"publisher","unstructured":"Napoli, N. et al. Mechanisms of diabetes mellitus-induced bone fragility, Nat. Rev. Endocrinol., vol. 13, no. 4, pp. 208\u2013219, Apr. (2017). https:\/\/doi.org\/10.1038\/nrendo.2016.153","DOI":"10.1038\/nrendo.2016.153"},{"key":"15227_CR8","doi-asserted-by":"publisher","unstructured":"Trojani, M. C., Santucci-Darmanin, S., Breuil, V., Carle, G. F. & Pierrefite-Carle, V. Autophagy and bone diseases. Joint Bone Spine. 89 (3), 105301. https:\/\/doi.org\/10.1016\/j.jbspin.2021.105301 (May 2022).","DOI":"10.1016\/j.jbspin.2021.105301"},{"key":"15227_CR9","doi-asserted-by":"publisher","unstructured":"Guo, Y. F. et al. Jun., The role of autophagy in bone homeostasis, J. Cell. Physiol., vol. 236, no. 6, pp. 4152\u20134173, (2021). https:\/\/doi.org\/10.1002\/jcp.30111","DOI":"10.1002\/jcp.30111"},{"key":"15227_CR10","doi-asserted-by":"publisher","unstructured":"Muralidharan, C. & Linnemann, A. K. \u03b2-cell autophagy in the pathogenesis of type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 321 (3), E410\u2013E416. https:\/\/doi.org\/10.1152\/ajpendo.00151.2021 (Sep. 2021).","DOI":"10.1152\/ajpendo.00151.2021"},{"key":"15227_CR11","doi-asserted-by":"publisher","unstructured":"Mohammadi-Motlagh, H. R. et al. \u03b2 cell and autophagy: what do we know? Biomolecules 13 (4). https:\/\/doi.org\/10.3390\/biom13040649 (Apr. 2023).","DOI":"10.3390\/biom13040649"},{"key":"15227_CR12","doi-asserted-by":"publisher","unstructured":"Wang, J. et al. Sep., The role of autophagy in bone metabolism and clinical significance, Autophagy, vol. 19, no. 9, pp. 2409\u20132427, (2023). https:\/\/doi.org\/10.1080\/15548627.2023.2186112","DOI":"10.1080\/15548627.2023.2186112"},{"key":"15227_CR13","doi-asserted-by":"publisher","first-page":"1091147","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"C Tong","year":"2022","unstructured":"Tong, C., Wu, Y., Zhang, L. & Yu, Y. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway. Front. Endocrinol. 13, 1091147. https:\/\/doi.org\/10.3389\/fendo.2022.1091147 (2022).","journal-title":"Front. Endocrinol."},{"key":"15227_CR14","doi-asserted-by":"publisher","unstructured":"Sadeghi, A. et al. Crosstalk between autophagy and insulin resistance: evidence from different tissues. Eur. J. Med. Res. 28 (1), 456. https:\/\/doi.org\/10.1186\/s40001-023-01424-9 (Oct. 2023).","DOI":"10.1186\/s40001-023-01424-9"},{"key":"15227_CR15","doi-asserted-by":"publisher","first-page":"708431","DOI":"10.3389\/fcell.2021.708431","volume":"9","author":"S Frendo-Cumbo","year":"2021","unstructured":"Frendo-Cumbo, S., Tokarz, V. L., Bilan, P. J., Brumell, J. H. & Klip, A. Communication between autophagy and insulin action: at the crux of insulin action-insulin resistance? Front. Cell. Dev. Biol. 9, 708431. https:\/\/doi.org\/10.3389\/fcell.2021.708431 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"15227_CR16","doi-asserted-by":"publisher","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (Jan. 2025).","DOI":"10.1093\/nar\/gkae909"},{"key":"15227_CR17","doi-asserted-by":"publisher","unstructured":"Aleksova, J., Ebeling, P. & Elder, G. The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease. Nat. Rev. Endocrinol. 21 (5), 301\u2013313. https:\/\/doi.org\/10.1038\/s41574-024-01083-8 (May 2025).","DOI":"10.1038\/s41574-024-01083-8"},{"key":"15227_CR18","doi-asserted-by":"publisher","unstructured":"Mohsin, S. et al. An update on therapies for the treatment of diabetes-induced osteoporosis, Expert Opin. Biol. Ther., vol. 19, no. 9, pp. 937\u2013948, Sep. (2019). https:\/\/doi.org\/10.1080\/14712598.2019.1618266","DOI":"10.1080\/14712598.2019.1618266"},{"key":"15227_CR19","doi-asserted-by":"publisher","unstructured":"Zhao, Y. et al. Dec., The potential of natural compounds regulating autophagy in the treatment of osteoporosis, J. Inflamm. Res., vol. Volume 16, pp. 6003\u20136021, (2023). https:\/\/doi.org\/10.2147\/JIR.S437067","DOI":"10.2147\/JIR.S437067"},{"key":"15227_CR20","doi-asserted-by":"publisher","unstructured":"Ou, Y., Zhao, Y. L. & Su, H. Pancreatic \u03b2-cells, diabetes and autophagy. Endocr. Res. 50 (1), 12\u201327. https:\/\/doi.org\/10.1080\/07435800.2024.2413064 (Feb. 2025).","DOI":"10.1080\/07435800.2024.2413064"},{"key":"15227_CR21","doi-asserted-by":"publisher","unstructured":"Marini, F., Giusti, F., Palmini, G. & Brandi, M. L. Role of wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders, Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA, vol. 34, no. 2, pp. 213\u2013238, Feb. (2023). https:\/\/doi.org\/10.1007\/s00198-022-06523-7","DOI":"10.1007\/s00198-022-06523-7"},{"key":"15227_CR22","doi-asserted-by":"publisher","unstructured":"Chen, X. et al. Irisin promotes osteogenic differentiation of bone marrow mesenchymal stem cells by activating autophagy via the wnt\/\/\u03b2-catenin signal pathway. Cytokine 136, 155292. https:\/\/doi.org\/10.1016\/j.cyto.2020.155292 (Dec. 2020).","DOI":"10.1016\/j.cyto.2020.155292"},{"key":"15227_CR23","doi-asserted-by":"publisher","unstructured":"Zhu, S. et al. HIF-1\u03b1-mediated autophagy and canonical wnt\/\u03b2-catenin signalling activation are involved in fluoride-induced osteosclerosis in rats, Environ. Pollut. Barking Essex 1987, vol. 315, p. 120396, Dec. (2022). https:\/\/doi.org\/10.1016\/j.envpol.2022.120396","DOI":"10.1016\/j.envpol.2022.120396"},{"key":"15227_CR24","doi-asserted-by":"publisher","unstructured":"Yang, B., Gan, M. S., Lin, Z. Y. & Wang, Z. F. Identification of autophagy-related genes as potential biomarkers for type 1 diabetes mellitus, Ann. Transl. Med., vol. 10, no. 11, p. 637, Jun. (2022). https:\/\/doi.org\/10.21037\/atm-22-1812","DOI":"10.21037\/atm-22-1812"},{"key":"15227_CR25","unstructured":"Brunetti, G., D\u2019Amato, G., Santis, S. D., Grano, M. & Faienza, M. F. Mechanisms of altered bone remodeling in children with type 1 diabetes."},{"key":"15227_CR26","doi-asserted-by":"publisher","unstructured":"Andreev, D. et al. Aug., Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin, J. Clin. Invest., vol. 130, no. 9, pp. 4811\u20134830, (2020). https:\/\/doi.org\/10.1172\/JCI134214","DOI":"10.1172\/JCI134214"},{"key":"15227_CR27","doi-asserted-by":"publisher","unstructured":"Haider, M. J. A., Albaqsumi, Z., Al-Mulla, F., Ahmad, R. & Al-Rashed, F. SOCS3 regulates dectin-2-induced inflammation in PBMCs of diabetic patients. Cells 11 (17). https:\/\/doi.org\/10.3390\/cells11172670 (Aug. 2022).","DOI":"10.3390\/cells11172670"},{"key":"15227_CR28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2147\/DMSO.S355749","volume":"15","author":"SJ Zheng","year":"2022","unstructured":"Zheng, S. J., Luo, Y. & Xiao, J. H. The impact of intestinal microorganisms and their metabolites on type 1 diabetes mellitus. Diabetes Metab. Syndr. Obes. Targets Ther. 15, 1123\u20131139. https:\/\/doi.org\/10.2147\/DMSO.S355749 (2022).","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"15227_CR29","doi-asserted-by":"publisher","unstructured":"Daamouch, S., Emini, L., Rauner, M. & Hofbauer, L. C. MicroRNA and diabetic bone disease. Curr. Osteoporos. Rep. 20 (3), 194\u2013201. https:\/\/doi.org\/10.1007\/s11914-022-00731-0 (Jun. 2022).","DOI":"10.1007\/s11914-022-00731-0"},{"key":"15227_CR30","doi-asserted-by":"publisher","unstructured":"Grieco, G. E. et al. Serum levels of miR-148a and miR-21-5p are increased in type 1 diabetic patients and correlated with markers of bone strength and metabolism. Non-Coding RNA. 4 (4), 37. https:\/\/doi.org\/10.3390\/ncrna4040037 (Nov. 2018).","DOI":"10.3390\/ncrna4040037"},{"key":"15227_CR31","unstructured":"miR-26a attenuated bone-specific insulin resistance and bone quality in diabetic mice - PubMed. Accessed: Jul. 05, 2025. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/32278305\/"},{"key":"15227_CR32","doi-asserted-by":"publisher","first-page":"7866720","DOI":"10.1155\/2021\/7866720","volume":"2021","author":"Y Lou","year":"2021","unstructured":"Lou, Y. et al. Inhibition of the Keap1\/Nrf2 signaling pathway significantly promotes the progression of type 1 diabetes mellitus. Oxid. Med. Cell. Longev. 2021, 7866720. https:\/\/doi.org\/10.1155\/2021\/7866720 (2021).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"15227_CR33","doi-asserted-by":"publisher","unstructured":"Chen, H. et al. Mar., Formononetin, a bioactive isoflavonoid constituent from astragalus membranaceus (fisch.) bunge, ameliorates type 1 diabetes mellitus via activation of Keap1\/Nrf2 signaling pathway: an integrated study supported by network pharmacology and experimental validation, J. Ethnopharmacol., vol. 322, p. 117576, (2024). https:\/\/doi.org\/10.1016\/j.jep.2023.117576","DOI":"10.1016\/j.jep.2023.117576"},{"key":"15227_CR34","doi-asserted-by":"publisher","unstructured":"Priddy, C. & Li, J. The role of the Nrf2\/Keap1 signaling cascade in mechanobiology and bone health. Bone Rep. 15, 101149. https:\/\/doi.org\/10.1016\/j.bonr.2021.101149 (Dec. 2021).","DOI":"10.1016\/j.bonr.2021.101149"},{"key":"15227_CR35","doi-asserted-by":"publisher","unstructured":"Fischer, V. & Haffner-Luntzer, M. Interaction between bone and immune cells: implications for postmenopausal osteoporosis. Semin Cell. Dev. Biol. 123, 14\u201321. https:\/\/doi.org\/10.1016\/j.semcdb.2021.05.014 (Mar. 2022).","DOI":"10.1016\/j.semcdb.2021.05.014"},{"key":"15227_CR36","doi-asserted-by":"publisher","unstructured":"Ilonen, J., Lempainen, J. & Veijola, R. The heterogeneous pathogenesis of type 1 diabetes mellitus, Nat. Rev. Endocrinol., vol. 15, no. 11, pp. 635\u2013650, Nov. (2019). https:\/\/doi.org\/10.1038\/s41574-019-0254-y","DOI":"10.1038\/s41574-019-0254-y"},{"key":"15227_CR37","doi-asserted-by":"publisher","unstructured":"Haacke, N. et al. Feb., Innate immune training of osteoclastogenesis promotes inflammatory bone loss in mice, Dev. Cell, pp. S1534-5807(25)63\u20132, (2025). https:\/\/doi.org\/10.1016\/j.devcel.2025.02.001","DOI":"10.1016\/j.devcel.2025.02.001"},{"key":"15227_CR38","doi-asserted-by":"publisher","unstructured":"Barbosa-Nu\u00f1ez, J. A. et al. Proteins and peptides responsible for bone remodeling. Differ. Res. Biol. Divers. 144, 100872. https:\/\/doi.org\/10.1016\/j.diff.2025.100872 (May 2025).","DOI":"10.1016\/j.diff.2025.100872"},{"key":"15227_CR39","doi-asserted-by":"publisher","unstructured":"Thong, E. P. et al. Jun., The diabetes-fracture association in women with type 1 and type 2 diabetes is partially mediated by falls: a 15-year longitudinal study, Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA, vol. 32, no. 6, pp. 1175\u20131184, (2021). https:\/\/doi.org\/10.1007\/s00198-020-05771-9","DOI":"10.1007\/s00198-020-05771-9"},{"key":"15227_CR40","doi-asserted-by":"publisher","unstructured":"Cui, R. et al. Jun., The relationship between atherosclerosis and bone mineral density in patients with type 2 diabetes depends on vascular calcifications and sex, Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA, vol. 31, no. 6, pp. 1135\u20131143, (2020). https:\/\/doi.org\/10.1007\/s00198-020-05374-4","DOI":"10.1007\/s00198-020-05374-4"},{"key":"15227_CR41","doi-asserted-by":"publisher","unstructured":"Adami, G. Regulation of bone mass in inflammatory diseases. Best Pract. Res. Clin. Endocrinol. Metab. 36 (2), 101611. https:\/\/doi.org\/10.1016\/j.beem.2021.101611 (Mar. 2022).","DOI":"10.1016\/j.beem.2021.101611"},{"key":"15227_CR42","doi-asserted-by":"publisher","unstructured":"Szentp\u00e9tery, \u00c1. et al. Effects of targeted therapies on the bone in arthritides. Autoimmun. Rev. 16 (3), 313\u2013320. https:\/\/doi.org\/10.1016\/j.autrev.2017.01.014 (Mar. 2017).","DOI":"10.1016\/j.autrev.2017.01.014"},{"key":"15227_CR43","doi-asserted-by":"publisher","unstructured":"Heiland, G. R. et al. Dec., Neutralisation of dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression, Ann. Rheum. Dis., vol. 69, no. 12, pp. 2152\u20132159, (2010). https:\/\/doi.org\/10.1136\/ard.2010.132852","DOI":"10.1136\/ard.2010.132852"},{"key":"15227_CR44","doi-asserted-by":"publisher","unstructured":"Herman, S., Kr\u00f6nke, G. & Schett, G. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy. Trends Mol. Med. 14 (6), 245\u2013253. https:\/\/doi.org\/10.1016\/j.molmed.2008.04.001 (Jun. 2008).","DOI":"10.1016\/j.molmed.2008.04.001"},{"key":"15227_CR45","doi-asserted-by":"publisher","unstructured":"Deal, C. Bone loss in rheumatoid arthritis: systemic, periarticular, and focal, Curr. Rheumatol. Rep., vol. 14, no. 3, pp. 231\u2013237, Jun. (2012). https:\/\/doi.org\/10.1007\/s11926-012-0253-7","DOI":"10.1007\/s11926-012-0253-7"},{"key":"15227_CR46","doi-asserted-by":"publisher","unstructured":"Jiang, Z. et al. CPNE1 Silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells. Oncol. Rep. 39 (2), 643\u2013650. https:\/\/doi.org\/10.3892\/or.2017.6128 (Feb. 2018).","DOI":"10.3892\/or.2017.6128"},{"key":"15227_CR47","doi-asserted-by":"publisher","unstructured":"Tomsig, J. L. & Creutz, C. E. Copines: a ubiquitous family of Ca(2+)-dependent phospholipid-binding proteins, Cell. Mol. Life Sci. CMLS, vol. 59, no. 9, pp. 1467\u20131477, Sep. (2002). https:\/\/doi.org\/10.1007\/s00018-002-8522-7","DOI":"10.1007\/s00018-002-8522-7"},{"key":"15227_CR48","doi-asserted-by":"publisher","unstructured":"Su, J. et al. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma. Cancer Cell. Int. 22 (1), 67. https:\/\/doi.org\/10.1186\/s12935-022-02485-2 (Feb. 2022).","DOI":"10.1186\/s12935-022-02485-2"},{"key":"15227_CR49","doi-asserted-by":"publisher","unstructured":"Yao, Z., Getting, S. J. & Locke, I. C. Regulation of TNF-induced osteoclast differentiation. Cells 11 (1). https:\/\/doi.org\/10.3390\/cells11010132 (Dec. 2021).","DOI":"10.3390\/cells11010132"},{"key":"15227_CR50","doi-asserted-by":"publisher","first-page":"1109296","DOI":"10.3389\/fendo.2023.1109296","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Effect of bifidobacterium on osteoclasts: TNF-\u03b1\/NF-\u03baB inflammatory signal pathway-mediated mechanism. Front. Endocrinol. 14, 1109296. https:\/\/doi.org\/10.3389\/fendo.2023.1109296 (2023).","journal-title":"Front. Endocrinol."},{"key":"15227_CR51","doi-asserted-by":"crossref","unstructured":"Katoh, M. WNT3-WNT14B and WNT3A-WNT14 gene clusters (review), Int. J. Mol. Med., vol. 9, no. 6, pp. 579\u2013584, Jun. (2002).","DOI":"10.3892\/ijmm.9.6.579"},{"issue":"8","key":"15227_CR52","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ncb2082","volume":"12","author":"C Gao","year":"2010","unstructured":"Gao, C. et al. Autophagy negatively regulates Wnt signalling by promoting dishevelled degradation. Nat. Cell. Biol. 12 (8), 781\u2013790 (2010).","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"15227_CR53","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3892\/etm.2022.11366","volume":"24","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Insulin and liraglutide attenuate brain pathology in diabetic mice by enhancing the wnt\/\u03b2-catenin signaling pathway. Exp. Ther. Med. 24 (1), 439 (2022).","journal-title":"Exp. Ther. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15227-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15227-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T22:49:25Z","timestamp":1757371765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15227-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15227"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15227-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29387"}}